27 Jan Communication to industry on ranitidine-containing medicines
Posted at 08:16h
in
The South African Health Products Regulatory Authority (SAHPRA), in collaboration with other regulatory agencies, are reviewing all ranitidine-containing medicines with the following Active Pharmaceutical Ingredient; ranitidine. SAHPRA previously issued a media release regarding the recall and quarantine of ranitidine containing medicines (29 October 2019 and 20 January 2020).
2020 Oct
Download latest version
Document Number:
2.18
Version:
1
Date Updated:
21/10/2020
File Type:
pdf
Category:
Communication to industry